Position in AMGN
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$1,976,813
+$1,081,355 QoQ
Shares Held
5,459
+114.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#1,286
of 3,140 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Bridgewater Advisors Inc. holds $24,557,436 across 14 Drug Manufacturers - General names. AMGN ranks #5 (8.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
22,989 | $5,838,516 | |
| 2 | LLY |
ELI LILLY & Co
|
3,983 | $4,777,330 | |
| 3 | MRK |
Merck & Co., Inc.
|
23,905 | $3,071,792 | |
| 4 | ABBV |
AbbVie Inc.
|
9,702 | $2,441,411 | |
| 5 | AMGN |
Amgen Inc
This page
|
5,459 | $1,976,813 | |
| 6 | NVS |
Novartis AG
|
10,369 | $1,625,029 | |
| 7 | PFE |
Pfizer Inc
|
62,287 | $1,499,870 | |
| 8 | AZN |
Astrazeneca PLC
|
4,442 | $842,292 |
All Filings in AMGN
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,976,813 | 5,459 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $895,458 | 2,545 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $814,347 | 2,488 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $690,825 | 2,448 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $680,434 | 2,437 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $750,523 | 2,409 | Shares | Sole | 2025-05-02 | |
| No filing history on record for this holder in this stock. | ||||||